查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1928945

合成生物学市场机会、成长要素、产业趋势分析及预测（2026-2035年）

Synthetic Biology Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 210 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球合成生物学市场预计到 2025 年将达到 256 亿美元，到 2035 年将达到 1,281 亿美元，年复合成长率为 17.5%。

合成生物学市场-IMG1

合成生物学透过将工程原理与生物学结合，设计出新的生物构件、装置和系统，彻底改变了生物系统的建构方式。该领域已从简单的基因工程发展到能够精确编程细胞功能的高级平台。这一转变得益于DNA合成和定序技术、计算生物学的突破以及对生物设计的深刻理解。市场涵盖平台产品，例如寡核苷酸、酵素和底盘生物体；核心产品，例如合成基因、细胞和DNA文库；以及应用产品，例如药物、工业化学品、生质燃料和生物材料。 CRISPR-Cas9等前沿基因组编辑技术正在加速合成生物学在治疗、农业和工业领域的应用，同时为传统的资源密集型製程提供永续的替代方案。

市场覆盖范围
开始年份 2025
预测年份 2026-2035
起始值 256亿美元
预测金额 1281亿美元
复合年增长率 17.5%

平台产品市场预计到2025年将达到115亿美元，到2035年将以16.5%的复合年增长率成长。此类别涵盖合成生物学研发所需的关键工具和试剂，包括寡核苷酸、聚合酵素和连接酶等酶、克隆试剂盒、细菌、酵母和哺乳动物细胞株等平台生物体，以及用于设计和模拟的软体平台。其市场主导地位反映了这些产品在支持所有合成生物学工作中所发挥的基础性作用。

预计到2025年，药物和治疗领域市场规模将达到102亿美元，到2035年将以14.5%的复合年增长率成长。这领域涵盖细胞和基因疗法、mRNA疫苗、生技药品製剂和生物合成小分子药物。随着多种产品获得商业性和临床检验，药物和治疗领域已成为合成生物学中商业性程度最高的领域。

美国合成生物学市场预计到 2025 年将达到 86 亿美元，到 2035 年将达到 431 亿美元。政府的大力支持推动了研发工作，2020 年多个机构拨款 1.61 亿美元用于生物製造和生质能源，2022 年能源部拨款 1.78 亿美元用于开发石油基产品的永续替代品。

目录

第一章调查方法和范围

第二章执行摘要

第三章业界考察

  • 生态系分析
    • 供应商情况
    • 利润率
    • 每个阶段的附加价值
    • 影响价值链的因素
    • 中断
  • 产业影响因素
    • 司机
    • 产业潜在风险与挑战
    • 市场机会
  • 成长潜力分析
  • 监管环境
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特分析
  • PESTEL 分析
  • 价格趋势
    • 按地区
  • 未来市场趋势
  • 科技与创新趋势
    • 当前技术趋势
    • 新兴技术
  • 专利状态
  • 贸易统计（HS编码）（註：仅提供主要国家的贸易统计）
    • 主要进口国
    • 主要出口国
  • 永续性和环境方面
    • 永续努力
    • 减少废弃物策略
    • 生产中的能源效率
    • 环保倡议
  • 碳足迹考量

第四章 竞争情势

  • 介绍
  • 公司市占率分析
    • 按地区
      • 北美洲
      • 欧洲
      • 亚太地区
      • 拉丁美洲
      • 中东和非洲
  • 企业矩阵分析
  • 主要市场公司的竞争分析
  • 竞争定位矩阵
  • 重大进展
    • 併购
    • 伙伴关係与合作
    • 新产品发布
    • 扩张计划

第五章 依产品类型分類的市场规模及预测（2022-2035年）

  • 核心产品
    • 合成核酸
    • 基因组编辑工具与试剂
    • 酵素和蛋白质
    • 基础生物体和细胞株
    • 基因部分载体
    • 其他的
  • 平台产品
    • 生物资讯学和计算工具
    • 自动化和机器人技术
    • 微流体与实验室晶片
    • 其他的
  • 已实现产品
    • 治疗产品
    • 生质燃料和可再生能源
    • 生物基化学品和材料
    • 食品和营养产品
    • 农产品
    • 诊断/生物感测器
    • 其他的

第六章 依技术分類的市场规模及预测（2022-2035年）

  • 核苷酸合成与定序技术
  • 基因工程技术
  • 生物资讯学和计算生物学
  • 微流体和小型化
  • 其他的

第七章 依应用领域分類的市场规模及预测（2022-2035年）

  • 药品和治疗药物
    • 细胞和基因治疗
    • 生物製品生产
    • 疫苗研发
    • 药物发现与开发
  • 诊断和生物感测
    • 医学诊断
    • 环境监测
    • 食品安全与品质
    • 生物防御与安全
  • 工业化学品/材料
    • 特用化学品
    • 聚合物和塑料
    • 工业酵素
    • 生物材料和纤维
  • 农业和食品生产
    • 作物改良
    • 农业生物製品
    • 畜牧业和水产养殖
    • 食品原料/添加物
  • 能源与生质燃料
    • 第一代和第二代生质燃料
    • 先进生质燃料
    • 氢能和新兴燃料
    • 原料转化
  • 环境应用技术
    • 生物修復
    • 碳捕获与利用
    • 污水处理
    • 环境监测网络
  • 其他的

第八章 依底盘类型分類的市场规模及预测（2022-2035年）

  • 细菌底盘
  • 酵母底盘
  • 哺乳动物细胞底盘
  • 植物基底盘
  • 藻类和光合作用底盘
  • 其他的

第九章 2022-2035年各地区市场规模及预测

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

第十章：公司简介

  • Novozymes
  • BASF
  • GenScript
  • ATUM
  • Integrated DNA Technologies
  • Twist Bioscience
  • Biomax Informatics
  • Pareto Biotechnologies
  • Blue Heron
  • TeselaGenSyntrox
  • Thermo Fisher Scientific
  • Gevo Inc
  • Royal DSM
  • Bristol-Myers Squibb
  • Amyris
  • Genomatica
  • Synthetic Genomics
  • Codexis
  • Butamax Scarab Genomics
  • Scarab Genomics
  • MorphoSys
  • Ginkgo Bioworks
  • Evolva
  • Igenbio
简介目录
Product Code: 3385

The Global Synthetic Biology Market was valued at USD 25.6 billion in 2025 and is estimated to grow at a CAGR of 17.5% to reach USD 128.1 billion by 2035.

Synthetic Biology Market - IMG1

Synthetic biology is revolutionizing the way we engineer biological systems by integrating engineering principles with biology to design novel biological components, devices, and systems. The field has evolved from simple genetic engineering to advanced platforms that enable precise programming of cellular functions. This transformation is driven by breakthroughs in DNA synthesis and sequencing, computational biology, and deeper insights into biological design. The market spans enabling products such as oligonucleotides, enzymes, and chassis organisms; core products including synthetic genes, cells, and DNA libraries; and enabled products covering pharmaceuticals, industrial chemicals, biofuels, and biomaterials. Cutting-edge genome editing technologies like CRISPR-Cas9 have accelerated the adoption of synthetic biology across therapeutics, agriculture, and industrial sectors, while also offering sustainable alternatives to traditional resource-intensive processes.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$25.6 Billion
Forecast Value$128.1 Billion
CAGR17.5%

The enabling products segment reached USD 11.5 billion in 2025 and is expected to grow at a CAGR of 16.5% through 2035. This category includes essential tools and reagents required for synthetic biology R&D, such as oligonucleotides, enzymes like polymerases and ligases, cloning kits, chassis organisms like bacterial, yeast, and mammalian cell lines, and software platforms for design and simulation. Its dominance reflects the foundational role these products play in supporting all synthetic biology initiatives.

The pharmaceuticals and therapeutics segment reached USD 10.2 billion in 2025 and is projected to grow at a CAGR of 14.5% through 2035. This segment encompasses cell and gene therapies, mRNA vaccines, engineered biologics, and biosynthetic small molecules. Commercial and clinical validation has been achieved for multiple products, positioning pharmaceuticals and therapeutics as the most commercially advanced area of synthetic biology.

U.S. Synthetic Biology Market was valued at USD 8.6 billion in 2025 and is expected to reach USD 43.1 billion by 2035. Strong government backing supports research and development, including USD 161 million allocated by various agencies in 2020 for biomanufacturing and bioenergy, alongside USD 178 million from the Department of Energy in 2022 aimed at developing sustainable alternatives to petroleum-based products.

Leading companies in the Global Synthetic Biology Market include Novozymes, GenScript, Thermo Fisher Scientific, Ginkgo Bioworks, Twist Bioscience, Integrated DNA Technologies, ATUM, Blue Heron, Amyris, BASF, Biomax Informatics, Pareto Biotechnologies, Gevo Inc., Royal DSM, Bristol-Myers Squibb, Genomatica, Synthetic Genomics, Codexis, Butamax Scarab Genomics, MorphoSys, Evolva, and Igenbio. Key strategies adopted by synthetic biology companies to strengthen their market presence include investing heavily in research and development to create advanced, high-precision solutions, expanding product portfolios through acquisitions and strategic partnerships, and forming collaborations with academic and industrial research institutions. Companies are also focusing on scaling manufacturing capabilities, integrating AI and computational tools for better biological design, and entering emerging geographic markets to expand their global footprint.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Product type
    • 2.2.2 Technology
    • 2.2.3 Application
    • 2.2.4 Chassis type
  • 2.3 TAM analysis, 2026-2035
  • 2.4 CXO perspectives: Strategic imperatives
    • 2.4.1 Executive decision points
    • 2.4.2 Critical success factors
  • 2.5 Outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier landscape
    • 3.1.2 Profit margin
    • 3.1.3 Value addition at each stage
    • 3.1.4 Factor affecting the value chain
    • 3.1.5 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
    • 3.2.2 Industry pitfalls and challenges
    • 3.2.3 Market opportunities
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Porter';s analysis
  • 3.6 PESTEL analysis
  • 3.7 Price trends
    • 3.7.1 By region
  • 3.8 Future market trends
  • 3.9 Technology and innovation landscape
    • 3.9.1 Current technological trends
    • 3.9.2 Emerging technologies
  • 3.10 Patent landscape
  • 3.11 Trade statistics (HS code) (Note: the trade statistics will be provided for key countries only)
    • 3.11.1 Major importing countries
    • 3.11.2 Major exporting countries
  • 3.12 Sustainability and environmental aspects
    • 3.12.1 Sustainable practices
    • 3.12.2 Waste reduction strategies
    • 3.12.3 Energy efficiency in production
    • 3.12.4 Eco-friendly initiatives
  • 3.13 Carbon footprint considerations

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 Latin America
      • 4.2.1.5 Middle East & Africa
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Size and Forecast, By Product Type, 2022-2035 (USD Billion)

  • 5.1 Key trends
  • 5.2 Core products
    • 5.2.1 Synthetic nucleic acids
    • 5.2.2 Genome editing tools & reagents
    • 5.2.3 Enzymes & proteins
    • 5.2.4 Chassis organisms & cell lines
    • 5.2.5 Genetic parts & vectors
    • 5.2.6 Others
  • 5.3 Enabling products
    • 5.3.1 Bioinformatics & computational tools
    • 5.3.2 Automation & robotics
    • 5.3.3 Microfluidics & lab-on-chip
    • 5.3.4 Others
  • 5.4 Enabled products
    • 5.4.1 Therapeutic products
    • 5.4.2 Biofuels & renewable energy
    • 5.4.3 Bio-based chemicals & materials
    • 5.4.4 Food & nutrition products
    • 5.4.5 Agricultural products
    • 5.4.6 Diagnostics & biosensors
    • 5.4.7 Others

Chapter 6 Market Size and Forecast, By Technology, 2022-2035 (USD Billion)

  • 6.1 Key trends
  • 6.2 Nucleotide Synthesis & Sequencing Technologies
  • 6.3 Genetic Engineering Technologies
  • 6.4 Bioinformatics & Computational Biology
  • 6.5 Microfluidics & Miniaturization
  • 6.6 Others

Chapter 7 Market Size and Forecast, By Application, 2022-2035 (USD Billion)

  • 7.1 Key trends
  • 7.2 Pharmaceuticals & therapeutics
    • 7.2.1 Cell & gene therapies
    • 7.2.2 Biologics production
    • 7.2.3 Vaccine development
    • 7.2.4 Drug discovery & development
  • 7.3 Diagnostics & biosensing
    • 7.3.1 Medical diagnostics
    • 7.3.2 Environmental monitoring
    • 7.3.3 Food safety & quality
    • 7.3.4 Biodefense & security
  • 7.4 Industrial chemicals & materials
    • 7.4.1 Specialty chemicals
    • 7.4.2 Polymers & plastics
    • 7.4.3 Industrial enzymes
    • 7.4.4 Biomaterials & textiles
  • 7.5 Agriculture & food production
    • 7.5.1 Crop improvement
    • 7.5.2 Agricultural biologicals
    • 7.5.3 Livestock & aquaculture
    • 7.5.4 Food ingredients & additives
  • 7.6 Energy & biofuels
    • 7.6.1 First & second generation biofuels
    • 7.6.2 Advanced biofuels
    • 7.6.3 Hydrogen & emerging fuels
    • 7.6.4 Feedstock conversion
  • 7.7 Environmental applications
    • 7.7.1 Bioremediation
    • 7.7.2 Carbon capture & utilization
    • 7.7.3 Wastewater treatment
    • 7.7.4 Environmental monitoring networks
  • 7.8 Others

Chapter 8 Market Size and Forecast, By Chassis Type, 2022-2035 (USD Billion)

  • 8.1 Key trends
  • 8.2 Bacterial chassis
  • 8.3 Yeast chassis
  • 8.4 Mammalian cell chassis
  • 8.5 Plant chassis
  • 8.6 Algal & photosynthetic chassis
  • 8.7 Others

Chapter 9 Market Size and Forecast, By Region, 2022-2035 (USD Billion)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 UK
    • 9.3.2 Germany
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 South Korea
    • 9.4.5 Australia
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East & Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East & Africa

Chapter 10 Company Profiles

  • 10.1 Novozymes
  • 10.2 BASF
  • 10.3 GenScript
  • 10.4 ATUM
  • 10.5 Integrated DNA Technologies
  • 10.6 Twist Bioscience
  • 10.7 Biomax Informatics
  • 10.8 Pareto Biotechnologies
  • 10.9 Blue Heron
  • 10.10 TeselaGenSyntrox
  • 10.11 Thermo Fisher Scientific
  • 10.12 Gevo Inc
  • 10.13 Royal DSM
  • 10.14 Bristol-Myers Squibb
  • 10.15 Amyris
  • 10.16 Genomatica
  • 10.17 Synthetic Genomics
  • 10.18 Codexis
  • 10.19 Butamax Scarab Genomics
  • 10.20 Scarab Genomics
  • 10.21 MorphoSys
  • 10.22 Ginkgo Bioworks
  • 10.23 Evolva
  • 10.24 Igenbio